R
REVA Medical
Leader in bioresorbable polymer technologies for vascular applications
About REVA Medical
REVA Medical specializes in the development and commercialization of bioresorbable polymer technologies for vascular applications. The company primarily serves patients with coronary artery disease by providing an alternative to traditional metallic stents through its flagship product, the Fantom Encore. This drug-eluting bioresorbable vascular scaffold supports arteries during the healing process and gradually dissolves, allowing natural movement and function to return. Operating in the medical device market, REVA Medical targets healthcare providers and institutions that focus on cardiovascular treatments. The business model revolves around the research, development, and sale of its proprietary medical devices, generating revenue through product sales and potentially through licensing agreements.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Listing
- IPO 2010
- Employees
- 54
- Open positions
- 7
- Dealroom signal
- 43.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Surgery, Cardiology and cardiovascular, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Aug 2022 | $45M | $180M | BioStar Capital | ↗ |
| POST IPO EQUITY✓Other financing | Jun 2017 | $35M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for REVA Medical is 1.5K monthly website visits, down 42.3% over the last three months. REVA Medical's team grew 0% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
REVA Medical in the San Diego ecosystem
The REVA Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
BioStar Capital
Series B and later5 investors entered at this stage
Domain Associates
Cerberus Capital Management
Bain Capital
Medtronic
Goldman Sachs
Other known investors4 additional known investors
Brookside Capital- PNPneumRx
- SCSenrigan Capital
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about REVA Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See REVA Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






